Olga Renner

527 total citations
24 papers, 373 citations indexed

About

Olga Renner is a scholar working on Oncology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Olga Renner has authored 24 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Surgery and 8 papers in Nutrition and Dietetics. Recurrent topics in Olga Renner's work include Drug Transport and Resistance Mechanisms (11 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers) and Vitamin C and Antioxidants Research (7 papers). Olga Renner is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers) and Vitamin C and Antioxidants Research (7 papers). Olga Renner collaborates with scholars based in Germany and Switzerland. Olga Renner's co-authors include Eduard F. Stange, Sascha Venturelli, Markus Burkard, Matthias Schwab, Elke Schaeffeler, Christian Leischner, Pascale Fisel, Anne T. Nies, Ulrich M. Lauer and Stephan C. Bischoff and has published in prestigious journals such as PLoS ONE, Journal of Lipid Research and International Journal of Cancer.

In The Last Decade

Olga Renner

23 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Renner Germany 12 160 134 117 73 48 24 373
Toshiki Etani Japan 12 133 0.8× 180 1.3× 205 1.8× 155 2.1× 22 0.5× 75 571
Mario Falsaperla Italy 12 109 0.7× 138 1.0× 152 1.3× 220 3.0× 64 1.3× 37 598
Erjiang Zhao China 12 94 0.6× 85 0.6× 158 1.4× 72 1.0× 26 0.5× 22 351
Yuko Kita Japan 12 71 0.4× 77 0.6× 121 1.0× 57 0.8× 56 1.2× 21 382
Andrea Thueringer Austria 11 116 0.7× 156 1.2× 103 0.9× 70 1.0× 15 0.3× 13 490
Keitaro Iida Japan 10 95 0.6× 132 1.0× 151 1.3× 90 1.2× 8 0.2× 49 420
Morihiko Inamine Japan 16 136 0.8× 172 1.3× 156 1.3× 75 1.0× 18 0.4× 45 672
Hayato Urushima Japan 10 108 0.7× 44 0.3× 129 1.1× 52 0.7× 36 0.8× 19 389

Countries citing papers authored by Olga Renner

Since Specialization
Citations

This map shows the geographic impact of Olga Renner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Renner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Renner more than expected).

Fields of papers citing papers by Olga Renner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Renner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Renner. The network helps show where Olga Renner may publish in the future.

Co-authorship network of co-authors of Olga Renner

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Renner. A scholar is included among the top collaborators of Olga Renner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Renner. Olga Renner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burkard, Markus, Christian Leischner, Susanne Berchtold, et al.. (2024). Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron. Antioxidants. 13(9). 1095–1095. 4 indexed citations
2.
Leischner, Christian, Luigi Marongiu, Heike Niessner, et al.. (2023). Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer. Antioxidants. 12(4). 916–916. 4 indexed citations
3.
Burkard, Markus, Heike Niessner, Christian Leischner, et al.. (2023). High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma. Cells. 12(2). 254–254. 8 indexed citations
4.
Sinnberg, Tobias, Christian Leischner, Heike Niessner, et al.. (2022). Vitamin C Deficiency in Blood Samples of COVID-19 Patients. Antioxidants. 11(8). 1580–1580. 10 indexed citations
5.
Niessner, Heike, Markus Burkard, Christian Leischner, et al.. (2022). Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo. Cells. 11(7). 1229–1229. 2 indexed citations
6.
Berger, Alexander, Christian Leischner, Olga Renner, et al.. (2022). Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma. Pharmaceuticals. 15(4). 438–438. 15 indexed citations
7.
Burkard, Markus, Heike Niessner, Christian Leischner, et al.. (2021). Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model. Nutrients. 13(7). 2366–2366. 8 indexed citations
8.
Reustle, Anna, Pascale Fisel, Olga Renner, et al.. (2018). Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. International Journal of Cancer. 143(12). 3181–3193. 41 indexed citations
9.
Renner, Olga, et al.. (2014). Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals. United European Gastroenterology Journal. 2(3). 216–225. 16 indexed citations
10.
Fisel, Pascale, Olga Renner, Anne T. Nies, Matthias Schwab, & Elke Schaeffeler. (2014). Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research. Expert Opinion on Drug Metabolism & Toxicology. 10(3). 395–408. 30 indexed citations
11.
Renner, Olga, et al.. (2014). Association of FXR gene variants with cholelithiasis. Clinics and Research in Hepatology and Gastroenterology. 39(1). 68–79. 9 indexed citations
12.
Renner, Olga, et al.. (2013). Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease. BMC Gastroenterology. 13(1). 30–30. 30 indexed citations
13.
Renner, Olga, Oliver J. Müller, Elke Schäffeler, et al.. (2012). MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha. Journal of Proteomics. 75(12). 3386–3399. 4 indexed citations
14.
Tönjes, Anke, Henning Wittenburg, Jan Halbritter, et al.. (2011). Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts. BMC Medical Genetics. 12(1). 149–149. 6 indexed citations
15.
Renner, Olga, Elke Schaeffeler, Stefan Winter, et al.. (2009). A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease. PLoS ONE. 4(10). e7321–e7321. 27 indexed citations
16.
Renner, Olga, Elke Schaeffeler, Matthias Schwab, et al.. (2009). Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression. Human Genetics. 125(4). 381–391. 19 indexed citations
17.
18.
Renner, Olga, et al.. (2008). Reduced ileal expression of OSTα-OSTβ in non-obese gallstone disease. Journal of Lipid Research. 49(9). 2045–2054. 35 indexed citations
19.
Renner, Olga, et al.. (2005). Increased association with detergent-resistant membranes/lipid rafts of apically targeted mutants of the interleukin-6 receptor gp80. European Journal of Cell Biology. 84(10). 819–831. 4 indexed citations
20.
Dietzel, Birgit, et al.. (1973). [On the specifity of human serum paraoxonase (author's transl)].. PubMed. 354(3). 337–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiki Etani Breakdown of academic impact, for papers by Mario Falsaperla Breakdown of academic impact, for papers by Erjiang Zhao Breakdown of academic impact, for papers by Yuko Kita Breakdown of academic impact, for papers by Andrea Thueringer Breakdown of academic impact, for papers by Keitaro Iida Breakdown of academic impact, for papers by Morihiko Inamine Breakdown of academic impact, for papers by Hayato Urushima
Rankless by CCL
2026